Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 4 | 2019 | 213 | 0.780 |
Why?
|
| Glaucoma, Neovascular | 1 | 2021 | 5 | 0.770 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2020 | 9 | 0.680 |
Why?
|
| Ophthalmology | 2 | 2017 | 45 | 0.640 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 130 | 0.630 |
Why?
|
| Remote Consultation | 1 | 2017 | 16 | 0.540 |
Why?
|
| Pseudotumor Cerebri | 1 | 2017 | 17 | 0.540 |
Why?
|
| Retina | 1 | 2017 | 225 | 0.470 |
Why?
|
| Delivery of Health Care | 3 | 2019 | 434 | 0.330 |
Why?
|
| Tomography, Optical Coherence | 3 | 2020 | 149 | 0.320 |
Why?
|
| Glaucoma | 2 | 2019 | 35 | 0.310 |
Why?
|
| Cataract | 2 | 2019 | 87 | 0.310 |
Why?
|
| Macular Degeneration | 2 | 2019 | 63 | 0.300 |
Why?
|
| Diabetic Retinopathy | 2 | 2019 | 92 | 0.300 |
Why?
|
| Bufanolides | 2 | 2018 | 5 | 0.280 |
Why?
|
| Visual Acuity | 3 | 2020 | 221 | 0.230 |
Why?
|
| Nerve Fibers | 2 | 2020 | 49 | 0.210 |
Why?
|
| Retinal Ganglion Cells | 2 | 2020 | 72 | 0.210 |
Why?
|
| Eye Burns | 1 | 2020 | 6 | 0.180 |
Why?
|
| Resistance Training | 1 | 2020 | 13 | 0.180 |
Why?
|
| Eye Injuries | 1 | 2020 | 14 | 0.180 |
Why?
|
| Keratitis | 1 | 2020 | 21 | 0.180 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 21 | 0.170 |
Why?
|
| Wet Macular Degeneration | 1 | 2020 | 27 | 0.170 |
Why?
|
| Cornea | 1 | 2020 | 70 | 0.170 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 58 | 0.170 |
Why?
|
| Equipment Failure | 1 | 2020 | 123 | 0.170 |
Why?
|
| Retrospective Studies | 4 | 2021 | 9675 | 0.170 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 196 | 0.160 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 296 | 0.150 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2018 | 82 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2021 | 4466 | 0.150 |
Why?
|
| Fibrosis | 1 | 2018 | 239 | 0.140 |
Why?
|
| Veterans Health | 1 | 2017 | 17 | 0.140 |
Why?
|
| Biomedical Technology | 1 | 2017 | 23 | 0.130 |
Why?
|
| Eye Diseases | 1 | 2017 | 60 | 0.130 |
Why?
|
| Ocular Hypertension | 3 | 2020 | 8 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2018 | 322 | 0.120 |
Why?
|
| Carica | 1 | 2015 | 1 | 0.120 |
Why?
|
| Chromosomes, Plant | 1 | 2015 | 36 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 810 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2015 | 253 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 151 | 0.110 |
Why?
|
| Child, Preschool | 1 | 2020 | 3812 | 0.100 |
Why?
|
| Humans | 10 | 2021 | 92175 | 0.100 |
Why?
|
| Haplotypes | 1 | 2015 | 638 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1591 | 0.100 |
Why?
|
| Male | 8 | 2020 | 43858 | 0.080 |
Why?
|
| Risk Factors | 1 | 2020 | 5697 | 0.080 |
Why?
|
| Child | 1 | 2020 | 7323 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2021 | 8725 | 0.080 |
Why?
|
| Adult | 5 | 2020 | 27494 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 9493 | 0.070 |
Why?
|
| Aged | 6 | 2020 | 19915 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2677 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2019 | 352 | 0.070 |
Why?
|
| Middle Aged | 6 | 2020 | 27001 | 0.060 |
Why?
|
| Heart Failure | 1 | 2015 | 1346 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2006 | 0.060 |
Why?
|
| Female | 7 | 2020 | 47822 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2790 | 0.050 |
Why?
|
| Tonometry, Ocular | 1 | 2020 | 11 | 0.040 |
Why?
|
| Exudates and Transudates | 1 | 2020 | 13 | 0.040 |
Why?
|
| Slit Lamp Microscopy | 1 | 2020 | 5 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 60 | 0.040 |
Why?
|
| Visual Fields | 1 | 2020 | 99 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2020 | 80 | 0.040 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2019 | 27 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6905 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 410 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 45 | 0.040 |
Why?
|
| Ouabain | 1 | 2018 | 24 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 89 | 0.040 |
Why?
|
| Physical Examination | 1 | 2019 | 151 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 200 | 0.040 |
Why?
|
| Georgia | 1 | 2017 | 40 | 0.030 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2017 | 34 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 601 | 0.030 |
Why?
|
| Health Services | 1 | 2017 | 56 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 556 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 1142 | 0.030 |
Why?
|
| Genes, Plant | 1 | 2015 | 99 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2504 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2015 | 623 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 499 | 0.030 |
Why?
|
| Mice | 2 | 2018 | 12103 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 450 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2015 | 499 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1076 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2015 | 1509 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2015 | 416 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1138 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 827 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 623 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1764 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 926 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2015 | 773 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 863 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1846 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2972 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 6615 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2443 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3356 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 3508 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 27974 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7338 | 0.010 |
Why?
|